Construction of a series of episomal plasmids and their application in the development of an efficient CRISPR/Cas9 system in Pichia pastoris.
CRISPR-Cas Systems
DNA Replication
Escherichia coli
/ genetics
Gene Dosage
Gene Editing
/ methods
Gene Expression Regulation, Fungal
Gene Knockout Techniques
Genetic Engineering
/ methods
Genetic Vectors
Genomic Instability
Industrial Microbiology
Kluyveromyces
/ genetics
Pichia
/ genetics
Plasmids
/ genetics
Promoter Regions, Genetic
RNA, Guide, Kinetoplastida
Synthetic Biology
Transformation, Genetic
Autonomously replicating sequence
CRISPR/Cas9
Episomal plasmid
Pichia pastoris
Synthetic biology
Journal
World journal of microbiology & biotechnology
ISSN: 1573-0972
Titre abrégé: World J Microbiol Biotechnol
Pays: Germany
ID NLM: 9012472
Informations de publication
Date de publication:
27 May 2019
27 May 2019
Historique:
received:
27
02
2019
accepted:
10
05
2019
entrez:
29
5
2019
pubmed:
28
5
2019
medline:
15
6
2019
Statut:
epublish
Résumé
The methylotrophic yeast Pichia pastoris is widely used in recombinant expression of eukaryotic proteins owing to the ability of post-translational modification, tightly regulated promoters, and high cell density fermentation. However, episomal plasmids for heterologous gene expression and the CRISPR/Cas9 system for genome editing have not been well developed in P. pastoris. In the present study, a panel of episomal plasmids containing various autonomously replicating sequences (ARSs) were constructed and their performance in transformation efficiency, copy numbers, and propagation stability were systematically compared. Among the five ARSs with different origins, panARS isolated from Kluyveromyces lactis was determined to have the best performance and used to develop an efficient CRISPR/Cas9 based genome editing system. Compared with a previously reported system using the endogenous and most commonly used ARS (PARS1), the CRISPR/Cas9 genome editing efficiency was increased for more than tenfold. Owing to the higher plasmid stability with panARS, efficient CRISPR/Cas9-mediated genome editing with a type III promoter (i.e. SER promoter) to drive the expression of the single guide RNA (sgRNA) was achieved for the first time. The constructed episomal plasmids and developed CRISPR/Cas9 system will be important synthetic biology tools for both fundamental studies and industrial applications of P. pastoris.
Identifiants
pubmed: 31134410
doi: 10.1007/s11274-019-2654-5
pii: 10.1007/s11274-019-2654-5
doi:
Substances chimiques
RNA, Guide
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
79Subventions
Organisme : National Key Research and Development Program of China
ID : 2018YFC1603900
Organisme : Natural Science Foundation of China
ID : 21576232
Organisme : Natural Science Foundation of China
ID : 21606205
Organisme : Natural Science Foundation of China
ID : 21808199
Organisme : Fundamental Research Funds for the Central Universities
ID : 2018QNA4039
Références
FEMS Microbiol Rev. 2000 Jan;24(1):45-66
pubmed: 10640598
Mol Biotechnol. 2000 Sep;16(1):23-52
pubmed: 11098467
Biotechniques. 2005 Jan;38(1):44, 46, 48
pubmed: 15679083
Biotechnol Lett. 2009 May;31(5):679-84
pubmed: 19152072
J Ind Microbiol Biotechnol. 2009 Nov;36(11):1435-8
pubmed: 19760441
Future Microbiol. 2013 Feb;8(2):191-208
pubmed: 23374125
Nucleic Acids Res. 2013 Apr;41(7):4336-43
pubmed: 23460208
Appl Microbiol Biotechnol. 2014 Jun;98(12):5301-17
pubmed: 24743983
Metab Eng. 2014 Jul;24:139-49
pubmed: 24853351
ACS Synth Biol. 2015 Mar 20;4(3):332-41
pubmed: 24959659
Front Bioeng Biotechnol. 2014 Nov 26;2:60
pubmed: 25505788
Nat Rev Mol Cell Biol. 2015 Sep;16(9):568-76
pubmed: 26081612
J Biotechnol. 2016 Oct 10;235:139-49
pubmed: 27015975
Biotechnol Bioeng. 2016 Nov;113(11):2462-73
pubmed: 27159405
Microb Cell Fact. 2016 Aug 11;15(1):139
pubmed: 27515025
Front Microbiol. 2017 May 02;8:780
pubmed: 28512458
Biotechnol Adv. 2017 Nov 1;35(6):681-710
pubmed: 28760369
Nat Commun. 2017 Nov 22;8(1):1688
pubmed: 29167442
Biotechnol Adv. 2018 May - Jun;36(3):641-665
pubmed: 29331410
Biotechnol J. 2018 Sep;13(9):e1700601
pubmed: 29436783
FEMS Microbiol Lett. 2018 Jun 1;365(11):null
pubmed: 29688335
Metab Eng. 2018 Nov;50:85-108
pubmed: 29702275
Metab Eng. 2018 Nov;50:2-15
pubmed: 29704654
Appl Environ Microbiol. 2018 Jul 17;84(15):
pubmed: 29802190
Metab Eng. 2018 Jul;48:279-287
pubmed: 29933064
Mol Cell Biol. 1985 Dec;5(12):3376-85
pubmed: 3915774